Well-known Canadian pot producer, Aurora Cannabis (NYSE:ACB), has yet again topped headlines with their recent press release. The company announced the Polish Ministry of Health approved them for their first shipment of medical marijuana to Poland. This makes Aurora Cannabis the first non-government ran business that has received approval to supply cannabis to the Polish market.
Chief Global Business Development Officer, Neil Belot, says that “becoming the first company to supply cannabis to Poland is validation of Aurora’s ability to do business in international markets with high barriers of entry.”
Not much was detailed about the deal, except that the company expects to ship products to a “pain treatment center and a hospital in Warsaw.”
Aurora Cannabis notably mentions it has the capacity to produce “in excess of 500,000 kg” per year, which is one of the largest capacities on the Canadian market. The company, to date, has acquired 15 wholly owned subsidiaries to further their production capacity and reach a larger target market.
Just this month, Aurora Cannabis reached a major milestone by getting listed on the New York Stock Exchange. Before this the company was only listed on the TSX and OTC market, making it tough to attract money and investors from the American markets.
The company’s primary operation is in Canada, but trough organic growth and strategic execution they have placed themselves in over 19 countries in 5 continents. This is awesome because Canada’s Senate recently passed Bill C-45 which legalizes recreational cannabis nationwide for anyone over 21.
With the recent nation-wide legalization in Canada, investors should be more aware to emerging cannabis markets around the globe. American investors who caught on early to the Canadian cannabis market saw gains of over 500% in just a 12-month span. In the past few years, legalization has swept the globe including countries like Canada, Poland, Germany, and even Uruguay.
Aurora Cannabis is teeing up to be a prime candidate for expanding into emerging cannabis markets. As we just saw, the company realized an opportunity in Poland and hopped on it immediately. The company also has already begun to dip their feet in the German market, which has already imported over 520,000 kilograms of medical cannabis from Canada in 2017.
As countries begin to legalize cannabis and new markets emerge, keep a close eye on Aurora Cannabis to see if they are making any moves into the market.
Read more about Aurora Cannabis here: Aurora Cannabis
Want to learn more about how to trade stocks and penny stocks? Get a free copy of our comprehensive eBook on stock trading here.
This article has been provided by a Bulls On The Street contributor. All content submitted by this author represent their personal opinions, and should be considered as such for entertainment purposes only. All opinions expressed are those of the writer, and may not necessarily represent fact, opinions, or bias of Bulls On The Street. We have not purchased shares of the aforementioned companies. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on Bullsonthestreet.com. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Bullsonthestreet.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.